Home > Care & Treatment > Clinical Trials > Clinical Trials Search Results
Participation Details: •30-day clinic visit •9-month clinic visit •Telephone follow-ups at 1 year, 2 years and 3 years
The Young Women's Breast Cancer Study
For patients with 1-3 positive nodes, hormone receptor positive and HER2 negative breast cancer with recurrence score (RS) of 25 or less.
• Standard of care clinic visits and ultrasounds
•Laboratory testing while in hospital •30 day clinic visit with laboratory testing •Telephone follow-up at 1 year
•Clinic visits during screening, randomization, week 1 and month 2 & every 6 months •Laboratory assessments at visits •participation is between 3 and 5 years
To help establish which treatments are effective in the treatment of Multiple Myeloma. This is a data registry and not a clinical trial that requires specific treatment regimes.
Phase II trial of combination Plerixafor (AMD3100), Bortezomib & Dexamethasone in relapsed or relapsed/refractory multiple myeloma.
Comparing conventional dose treatment using lenalidomide, bortezomib and dexamethasone (RVD) to high dose treatment with peripheral stem cell transplant.
A Phase II study of modified Lenalidomide, Bortezomib and Dexamethasone for transplant ineligible patients with newly diagnosed multiple myeloma.
Cape Cod Hospital 27 Park Street Hyannis MA 02601 Phone: 508-771-1800 Directions
Falmouth Hospital 100 Ter Heun Drive Falmouth, MA 02540 Phone: 508-548-5300 Directions